OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cholangiocarcinoma — novel biological insights and therapeutic strategies
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 87
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 87
Showing 1-25 of 87 citing articles:
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
Masuko Katoh, Yohann Loriot, Giovanni Brandi, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 312-329
Closed Access | Times Cited: 56
Masuko Katoh, Yohann Loriot, Giovanni Brandi, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 312-329
Closed Access | Times Cited: 56
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
The causal relationship between gut microbiota and biliary tract cancer: comprehensive bidirectional Mendelian randomization analysis
Kui Wang, Suijian Wang, Xianzheng Qin, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
Kui Wang, Suijian Wang, Xianzheng Qin, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis
YaLan Hu, Kui Wang, Yuhua Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
YaLan Hu, Kui Wang, Yuhua Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via exosomes in gastrointestinal tumors
Longyang Cao, Hong Ouyang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Longyang Cao, Hong Ouyang
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Manganese-based immunotherapy synergized with novel supramolecular hydrogel: Advancing localized immune activation strategies in squamous cell carcinoma
Tianqing Wang, Xiaopei Hu, Xin Tian, et al.
Materials & Design (2025), pp. 113632-113632
Open Access | Times Cited: 1
Tianqing Wang, Xiaopei Hu, Xin Tian, et al.
Materials & Design (2025), pp. 113632-113632
Open Access | Times Cited: 1
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma
Margaret Wheless, Rajiv Agarwal, Laura W. Goff, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 1, pp. 127-160
Open Access | Times Cited: 7
Margaret Wheless, Rajiv Agarwal, Laura W. Goff, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 1, pp. 127-160
Open Access | Times Cited: 7
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma
Emilien Loeuillard, Binbin Li, Hannah E. Stumpf, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 5, pp. 853-876
Open Access | Times Cited: 7
Emilien Loeuillard, Binbin Li, Hannah E. Stumpf, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 17, Iss. 5, pp. 853-876
Open Access | Times Cited: 7
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma
Jennifer L. Tomlinson, Binbin Li, Jingchun Yang, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 892-903
Open Access | Times Cited: 6
Jennifer L. Tomlinson, Binbin Li, Jingchun Yang, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 892-903
Open Access | Times Cited: 6
N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1
Jing Li, Xiaohong Xu, Kaihao Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Jing Li, Xiaohong Xu, Kaihao Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Natural Flavonoids Quercetin and Kaempferol Targeting G2/M Cell Cycle-Related Genes and Synergize with Smac Mimetic LCL-161 to Induce Necroptosis in Cholangiocarcinoma Cells
Thanpisit Lomphithak, Patthorn Jaikla, Apiwit Sae-Fung, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3090-3090
Open Access | Times Cited: 13
Thanpisit Lomphithak, Patthorn Jaikla, Apiwit Sae-Fung, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3090-3090
Open Access | Times Cited: 13
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice
Yan Yang, Jiale Wang, Jianhua Wan, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 1, pp. 120-134
Closed Access | Times Cited: 5
Yan Yang, Jiale Wang, Jianhua Wan, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 1, pp. 120-134
Closed Access | Times Cited: 5
Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 5
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 5
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Jasmin Elurbide, Leticia Colyn, M. Ujúe Latasa, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 116-127
Closed Access | Times Cited: 4
Jasmin Elurbide, Leticia Colyn, M. Ujúe Latasa, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 116-127
Closed Access | Times Cited: 4
Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
Liye Wang, Pan Li, Shuai Gong, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41600-e41600
Closed Access
Liye Wang, Pan Li, Shuai Gong, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41600-e41600
Closed Access
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yunyan Dai, Chenyang Dong, Zhiming Wang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Role of genomics in liver transplantation for cholangiocarcinoma
Nadine Soliman, Anaum Maqsood, Ashton A. Connor
Current Opinion in Organ Transplantation (2025)
Closed Access
Nadine Soliman, Anaum Maqsood, Ashton A. Connor
Current Opinion in Organ Transplantation (2025)
Closed Access
Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies
Jian‐Yang Ao, Mingtai Hu, Jinghan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jian‐Yang Ao, Mingtai Hu, Jinghan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
CDK4/6 inhibitors upregulate cIAP1/2, and Smac mimetic LCL161 enhances their antitumor effects in cholangiocarcinoma cells
Pimchanok Menapree, Nattaya Duangthim, Apiwit Sae-Fung, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pimchanok Menapree, Nattaya Duangthim, Apiwit Sae-Fung, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Frequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor role
Evodie Koutouan, Ayano Niibe, Jack W. Sample, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Evodie Koutouan, Ayano Niibe, Jack W. Sample, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC
Shoichi Kimura, Satoshi Iwano, Takahiro Akioka, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2308-2308
Open Access
Shoichi Kimura, Satoshi Iwano, Takahiro Akioka, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2308-2308
Open Access
Tumor-derived exosomal LINC01812 induces M2 macrophage polarization to promote perineural invasion in cholangiocarcinoma
Qinlei Wang, Zhaowei Sun, Jingyun Guo, et al.
Cancer Letters (2025) Vol. 617, pp. 217596-217596
Open Access
Qinlei Wang, Zhaowei Sun, Jingyun Guo, et al.
Cancer Letters (2025) Vol. 617, pp. 217596-217596
Open Access
The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer
Bing Zhong, Jintao Du, Feng Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Bing Zhong, Jintao Du, Feng Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Molecular signatures of intrahepatic Cholangiocarcinoma: Role in targeted therapy selection
Tetiana Glushko, James Costello, Ranjit S. Chima, et al.
European Journal of Radiology (2025), pp. 112056-112056
Closed Access
Tetiana Glushko, James Costello, Ranjit S. Chima, et al.
European Journal of Radiology (2025), pp. 112056-112056
Closed Access
NSUN5 promotes cholangiocarcinoma progression by enhancing GLS mRNA stabilization
Ming Shu, Kun‐Peng Guo, Yikai Huang, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 3
Open Access
Ming Shu, Kun‐Peng Guo, Yikai Huang, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 3
Open Access
